Other papers submitted by: Professor Joel Joel N. Buxbaum

open access to scientific and medical research

News:

Expressions of interest for Editor-in-Chief - the International Medical Case Reports Journal Read more

Back to User profile » Professor Joel Joel N. Buxbaum

Paper published by Professor Joel Joel N. Buxbaum:

Review

Highly-accessed

Evaluation of tafamidis as first-line therapeutic agent for transthyretin familial amyloidotic polyneuropathy

Buxbaum JN

Degenerative Neurological and Neuromuscular Disease 2012, 2:165-173

Published Date: 23 October 2012